CSEIX | GREIX | CSEIX / GREIX | |
Total Expense Ratio | 1.10 | 0.85 | 129% |
Annual Report Gross Expense Ratio | 1.10 | 1.21 | 91% |
Fund Existence | 28 years | 27 years | - |
Gain YTD | 4.709 | 1.162 | 405% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.3B | 64M | 12,975% |
Annual Yield % from dividends | 2.72 | 2.05 | 133% |
Returns for 1 year | -1.37 | -6.10 | 22% |
Returns for 3 years | 33.12 | 21.60 | 153% |
Returns for 5 years | 27.14 | 6.31 | 430% |
Returns for 10 years | 55.91 | -28.49 | -196% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BRWTX | 29.30 | N/A | N/A |
MFS Blended Research Growth Eq R3 | |||
NPSGX | 18.36 | N/A | N/A |
Nicholas Partners Small Cap Gr Instl | |||
JGYCX | 13.52 | N/A | N/A |
JHancock Global Shareholder Yield C | |||
JFNCX | 61.76 | N/A | N/A |
Janus Henderson Global Life Sciences C | |||
RICGX | 67.39 | -0.16 | -0.24% |
American Funds Invmt Co of Amer R6 |